Fig. 3From: Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective studyNomogram for predicting breast pCR in ER+, HER2− breast cancer patients after NACTBack to article page